Repatha 140 MG/ML sureclickml
Ended Awarded Last action
- Contract number
- SPE2DR26FJG8N
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $33,487
Award facts
- Contract value 100% obligated
- $33,486.51 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $33,486.51 to AmerisourceBergen Drug Corp for Repatha 140 mg/ml SureClick auto-injectors. This firm fixed-price, non-set-aside contract was executed on January 8, 2026, with an ultimate completion date of January 9, 2026. The award represents a task order under AmerisourceBergen's parent company Cencora, Inc.'s substantial Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 2026. This pharmaceutical supply vehicle enables the company to deliver a comprehensive range of medications and medical supplies to support military healthcare programs globally.
Repatha is a PCSK9 inhibitor indicated for the treatment of high cholesterol in patients with cardiovascular disease or at high risk for cardiovascular events. The delivery order reflects DLA's ongoing pharmaceutical procurement needs for military treatment facilities and veteran healthcare systems. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement and has consistently demonstrated capability to fulfill competitive federal requirements across multiple therapeutic domains through its extensive portfolio of brand-name and generic medications, vaccines, and specialized medical commodities.
Quick answers
Who was awarded contract SPE2DR26FJG8N?
SPE2DR26FJG8N was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 8, 2026.
How much is contract SPE2DR26FJG8N worth?
The government has obligated $33,487 on SPE2DR26FJG8N.
Is contract SPE2DR26FJG8N an order under another contract?
Yes. SPE2DR26FJG8N is a delivery order under SPE2DR25D1106, an indefinite delivery contract.
Was contract SPE2DR26FJG8N competed?
The extent of competition for SPE2DR26FJG8N was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award